SLC6A19 and phenylketonuria: B0AT1 has also been shown to lower elevated amino acid levels in mouse models of phenylketonuria and urea cycle disorders (Belanger et al., 2018; Seow et al., 2004) and may protect against kidney damage (Garrido et al., 2022).